Asana Inc
For the period ended Jan 31, 2024. Filed Mar 14, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 14, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Notes to Consolidated Financial Statements
Note 1. Organization
Organization and Description of Business
Asana, Inc. (“Asana” or the “Company”) was incorporated in the state of Delaware on December 16, 2008. Asana is a leading work management software platform with an enterprise focus that helps organizations orchestrate work, from daily tasks to cross-functional strategic initiatives. The Company is headquartered in San Francisco, California.
Note 2. Basis of Presentation and Summary of Significant Accounting Policies
Principles of Consolidation
The accompanying consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America (“GAAP”) and include the accounts of the Company’s wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated on consolidation.
Fiscal Year
The Company’s fiscal year ends on January 31. For example, references to fiscal 2024, 2023, and 2022 refer to the fiscal year ended January 31, 2024, January 31, 2023, and January 31, 2022, respectively.
Reclassification of Class A and Class B Common Stock
On March 23, 2020, the Company amended and restated its certificate of incorporation to effect a reclassification of the Company’s Class A common stock to Class B common stock, and vice versa. There were no changes to the rights, preferences, and privileges of each class of common stock at this time. All references to Class A common stock have been recast to Class B common stock, and all references to Class B common stock have been recast to Class A common stock, in these consolidated financial statements to give retrospective effect to the reclassification for all periods presented.
Use of Estimates
The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported and disclosed in the consolidated financial statements and accompanying notes. Estimates and assumptions reflected in the consolidated financial statements include, but are not limited to, revenue recognition, the useful lives and carrying values of long-lived assets, the fair value of the Convertible Notes (as defined in Note 6. Convertible Notes—Related Party), the fair value of common stock for periods prior to the Direct Listing, stock-based compensation expense, the period of benefit for deferred contract acquisition costs, income taxes, and the valuation of right-of-use assets. Actual results could differ from those estimates.
Risks and Uncertainties
Global macroeconomic events including elevated inflation, the U.S. Federal Reserve raising interest rates, bank failures, supply chain disruptions, fluctuations in currency exchange rates, the Russian invasion of Ukraine, the current armed conflict in Israel and the Gaza Strip, and the residual impact of the COVID-19 pandemic have led to economic uncertainty. These macroeconomic conditions have and are likely to continue to have adverse effects on the rate of global IT spending, including the buying patterns of the Company’s customers and prospective customers.
The conditions caused by the aforementioned macroeconomic events have affected and could continue to affect the rate of global IT spending and could adversely affect demand for the Company’s platform, lengthen the Company’s sales cycles, reduce the value or duration of subscriptions, negatively impact collections of accounts receivable, reduce expected spending from new customers, cause some of the Company’s paying customers to go out of business, and affect contraction or attrition rates of the Company’s customers, all of which could adversely affect the Company’s business, results of operations, and financial condition. As of the date of issuance of the financial statements, the Company is not aware of any specific event or circumstance related to the aforementioned macroeconomic events that would require it to update its estimates or judgments or adjust the carrying value of its assets or liabilities. Actual results could differ from those estimates and any such differences may be material to the consolidated financial statements.
Revenue Recognition
The Company derives its revenues from subscription fees earned from customers accessing the platform. The Company’s policy is to exclude sales and other indirect taxes when measuring the transaction price of its subscription agreements. The Company accounts for revenue contracts with customers by applying the requirements of ASC 606, Revenue from Contracts with Customers, which includes the following steps:
identification of the contract, or contracts, with the customer;
identification of the performance obligations in the contract;
determination of the transaction price;
allocation of the transaction price to the performance obligations in the contract; and
recognition of the revenues when, or as, the Company satisfies a performance obligation.
The Company’s subscription agreements generally have monthly or annual contractual terms and are billed in advance. Revenues are recognized ratably over the related contractual term beginning on the date that the platform is made available to a customer. The Company recognizes revenues ratably because the customer receives and consumes the benefits of the platform throughout the contractual period. Access to the platform represents a series of distinct services that comprise a single performance obligation that is satisfied over time. The Company’s contracts are generally non-cancelable and non-refundable in the event of cancellations.
Research and development expenses consist primarily of personnel-related expenses such as salaries and related benefits for the Company’s product development employees. Also included are non-personnel costs such as product design costs, third-party services and consulting expenses, depreciation expense related to equipment used in research and development activities, and allocation of the Company’s general overhead expenses.
Advertising Expenses
Advertising expenses are charged to sales and marketing expense in the consolidated statements of operations as incurred. Advertising expenses were $79.4 million,$118.1 million, and$87.4 million for the years ended January 31, 2024, 2023, and 2022, respectively.
Stock‑Based Compensation Expense
The Company records stock-based compensation expense for all stock-based awards, including stock options, purchase rights issued under the 2020 Employee Stock Purchase Plan, and restricted stock units, made to employees, non-employees, and directors based on estimated fair values recognized over the requisite service period. The fair value of stock options granted and purchase rights issued under the ESPP for purposes of calculating stock-based compensation expense is estimated on the grant date using the Black-Scholes pricing model. The Black-Scholes pricing model requires the Company to make assumptions and judgments about the inputs used in the calculation, including the expected term (weighted-average period of time that the options granted are expected to be outstanding), the volatility of the Company’s common stock, risk-free interest rate, and expected dividend yield. The expected term represents the period that the Company’s stock-based awards are expected to be outstanding. The expected term assumptions are determined based on the vesting terms, exercise terms, and contractual lives of the options. The volatility is based on an average of the historical volatilities of the common stock of comparable public companies with characteristics similar to those of the Company. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods corresponding with the expected life of the option. The
Company’s expected dividend yield input is zero as it has not historically paid, nor does it expect in the future to pay, cash dividends on its common stock. Stock-based compensation expense for RSUs is measured based on the fair value of the underlying shares on the date of grant.
Stock-based compensation expense is recognized as expense over the requisite service period, which is generally the vesting period of the respective award. The Company uses the straight-line method for expense attribution. The Company accounts for forfeitures as they occur.
Foreign Currency Translation and Transactions
The functional currency of each of the Company’s wholly owned subsidiaries is the applicable local currency or the U.S. dollar. The translation of foreign currencies into U.S. dollars is performed for assets and liabilities using current foreign currency exchange rates in effect at the balance sheet date and for revenues and expense accounts using average foreign currency exchange rates during the period. Capital accounts are translated at historical foreign currency exchange rates. Translation gains and losses are included in stockholders’ equity (deficit) as a component of accumulated other comprehensive income (loss). Adjustments that arise from foreign currency exchange rate changes on transactions denominated in a currency other than the functional currency are included in interest income and other income (expense), net on the consolidated statements of operations and were not material for the years ended January 31, 2024, 2023, and 2022.
Segment Information
The Company’s chief operating decision-maker is its Chief Executive Officer (“CEO”), who reviews financial information presented on a consolidated basis for purposes of making operating decisions, assessing financial performance, and allocating resources. The Company manages its operations and allocates resources as a single operating segment. For information regarding the Company’s revenues and long-lived assets by geographic area, see Note 15. Geographic Information.
Cash and Cash Equivalents
The Company considers all highly liquid investments with original maturities at the date of purchase of three months or less to be cash equivalents. Cash and cash equivalents are stated at cost, which approximates fair value.
Cash and cash equivalents as reported in the Company’s consolidated statements of cash flows includes the aggregate amounts of cash and cash equivalents as shown on the consolidated balance sheets.
Available-for-sale Investments
Marketable securities are partially comprised of U.S. government securities, commercial paper, corporate bonds, and agency bonds with an original contractual maturity or a remaining maturity at the time of purchase of greater than three months and no more than 37 months. The Company classifies its securities as available-for-sale at the time of purchase and reevaluates such classification at each balance sheet date. The Company may sell these securities at any time for use in current operations even if they have not yet reached maturity. As a result, the Company classifies its marketable securities, including securities with stated maturities beyond twelve months, within current assets in the condensed consolidated balance sheets.
Available-for-sale securities are carried at fair value with unrealized gains and losses reported in accumulated other comprehensive income (loss) as a separate component of stockholders’ equity (deficit). Unrealized gains and losses for any marketable securities that management intends to sell or is more likely than not that management will be required to sell prior to their anticipated recovery are recorded in interest income and other income (expense), net. Interest receivable on these securities is presented in prepaid expenses and other current assets on the consolidated balance sheets. Realized gains and losses, other-than-temporary impairments (prior to the Company’s adoption of ASU No. 2016-13 on February 1, 2021), and the recognition of expected credit losses (subsequent to the Company’s adoption of ASU No. 2016-13 on February 1, 2021), if any, on available-for-sale securities are recognized upon sale and are included in interest income and other income (expense), net in the consolidated statements of operations. The cost of securities sold is based on the specific identification method. Marketable securities are reviewed periodically to identify possible other-than-temporary impairments or expected credit losses. No impairment or credit loss has been recorded on the Company’s marketable securities during the years ended January 31, 2024, 2023, or 2022.
Accounts Receivable
Accounts receivable are stated at realizable value, net of allowance for expected credit losses. The allowance for expected credit losses is based on the Company’s assessment of the collectability of its accounts receivable, which considers the Company’s historical write-offs of uncollectible accounts, an analysis of the aging of outstanding accounts receivable, specific customers with known adverse financial conditions, and considers other relevant factors, including contractual terms and current and future economic conditions. The Company also considers current market conditions and current and future economic conditions in reviewing the adequacy of the allowance. The Company reassesses the adequacy of the allowance for credit losses each reporting period.
The Company’s allowance for expected credit losses was $2.3 million as of January 31, 2024 and 2023.
Concentration of Credit Risk
Financial instruments that potentially subject the Company to a concentration of credit risk consist of cash, cash equivalents, and marketable securities. The Company deposits its cash and cash equivalents with financial institutions that management believes are of high credit quality, although such deposits may, at times, exceed federally insured limits. The Company has not experienced any losses on its deposits of cash and cash equivalents to date. Cash equivalents are invested in highly rated securities.
The Company grants credit to customers in the normal course of business. For the years ended January 31, 2024, 2023, and 2022, there were no individual customers that accounted for 10% or more of the Company’s revenues. The Company had no customers that accounted for 10% or more of accounts receivable at January 31, 2024 and 2023.
Fair Value of Financial Instruments
Fair value is defined as the exit price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the reporting date. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. Fair value is estimated by utilizing a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows:
Level 1 Observable inputs comprised of quoted prices for identical assets or liabilities in active markets.
Level 2 Inputs other than the quoted prices in active markets that are observable either directly or indirectly.
Level 3 Unobservable inputs in which there is little or no market data and that are significant to the fair value of the assets or liabilities.
In determining fair value, a financial instrument’s classification within the three-tier fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. The Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible, as well as considers counterparty credit risk in its assessment of fair value.
The carrying amount of certain financial instruments, including cash, accounts receivable, accounts payable, and accrued liabilities approximates their fair values due to their short-term nature.
Lease Obligations
The Company determines if an arrangement is a lease at inception by determining if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration and other facts and circumstances. Right-of-use assets and lease liabilities are recognized at commencement date based on the present value of remaining lease payments over the lease term. For this purpose, the Company considers only payments that are fixed and determinable at the time of commencement. As the Company’s leases do not provide an implicit rate, the Company uses the incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The incremental borrowing rate is a hypothetical rate based on the Company’s understanding of what its credit rating would be. The ROU assets also include any lease payments made prior to commencement and are recorded net of any lease incentives received. The lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise such options. The lease agreements may contain variable costs such as common area maintenance, insurance, real estate taxes or other costs. Variable lease costs are expensed as incurred on the consolidated statements of operations. The Company’s lease agreements generally do not contain any residual value guarantees, restrictions, or covenants.
The Company has lease agreements with lease and non-lease components. The Company elects to combine lease and non-lease components as a single lease component for all classes of underlying assets. The Company elects to not record leases with an initial term of 12 months or less on the balance sheet and the associated lease payments are recognized in the consolidated statements of operations on a straight-line basis over the lease term.
Operating leases are included in operating lease ROU assets, operating lease liabilities, current, and operating lease liabilities, noncurrent on the consolidated balance sheets.
Property and Equipment, Net
The Company records its property and equipment at cost. Depreciation is computed on the straight-line method over the estimated useful lives oftwo tofive years. Leasehold improvements are amortized over the remaining period of the lease, or the estimated useful life of the improvement, whichever is shorter. Repair and maintenance expenditures, which are not considered improvements and do not extend the useful life of an asset, are expensed as incurred.
| Asset Type | Life (Years) |
|---|---|
| Desktop and other computer equipment | 2-3 |
| Furniture and fixtures | 5 |
| Leasehold improvements | Shorter of lease term or estimated useful life |
| Capitalized internal-use software | 3 |
Capitalized Internal-Use Software
The Company capitalizes certain internal software development costs, consisting primarily of direct labor associated with creating the internally developed software. Capitalized costs are amortized using the straight-line method over the estimated useful life of the software once it is ready for its intended use. The Company believes the straight-line recognition method best approximates the manner in which the expected benefit will be derived.
Impairment of Long-Lived Assets
The Company evaluates its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of such asset groups may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset group to future undiscounted cash flows expected to be generated by the asset group. If such assets are considered to be impaired, the impairment recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or fair value less costs to sell. The Company recorded a $5.0 million impairment charge during the year ended January 31, 2024. No impairment losses were recorded during the years ended January 31, 2023, and 2022. The $5.0 million impairment charge incurred during the year ended January 31, 2024 related to the right-of-use (“ROU”) assets and underlying property and equipment associated with the Company’s subleased office spaces is further described in Note 9. Leases to the consolidated financial statements.
Income Taxes
The Company accounts for income taxes under the asset and liability method, which requires that deferred income taxes be provided for temporary differences between the tax basis of the Company’s assets and liabilities and their financial statement reported amounts. In addition, deferred tax assets are recorded for the future benefit of utilizing net operating loss carryforwards and research and development credit carryforwards.
A valuation allowance is provided against deferred tax assets unless it is more likely than not that they will be realized. If there is significant negative evidence that the near-term realization of certain assets are deemed unlikely, the Company would record a valuation allowance against the deferred tax assets. The Company regularly assesses the continuing need for a valuation allowance against its deferred tax assets. Significant judgment is required to determine whether a valuation allowance continues to be necessary and the amount of such valuation allowance, if appropriate. The Company considers all available evidence, both positive and negative, to determine, based on the weight of available evidence, whether it is more likely than not that some or all of the deferred tax assets will not be realized. In evaluating the continued need for a valuation allowance, the Company considers, among other things, the nature, frequency, and severity of current and cumulative losses, forecasts of future profitability, and the duration of statutory carryforward periods.
The Company performs a comprehensive review of potential uncertain tax positions in each jurisdiction in which the Company operates. The Company accounts for uncertain tax positions in accordance with ASC 740, Income Taxes. ASC 740 prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax provision that an entity takes or expects to take in a tax return.
Net Loss Per Share
Basic and diluted net loss per share attributable to common stockholders is presented in conformity with the two-class method required for participating securities. All series of the Company’s redeemable convertible preferred stock and early exercised stock options are considered to be participating securities because all holders are entitled to receive a non-cumulative dividend on a pari passu basis in the event that a dividend is paid on the common stock. The holders of the redeemable convertible preferred stock do not have a contractual obligation to share in the Company’s losses. As such, the Company’s net losses for the years ended January 31, 2024, 2023, and 2022 were not allocated to these participating securities.
The rights, including the liquidation and dividend rights, of the holders of Class A and Class B common stock are identical, except with respect to voting. As the liquidation and dividend rights are identical, the undistributed earnings are allocated on a proportionate basis and the resulting net loss per share attributed to common stockholders will, therefore, be the same for both Class A and Class B common stock on an individual or combined basis.
Under the two-class method, basic net loss per share attributable to common stockholders is computed by dividing the net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period.
Diluted earnings per share attributable to common stockholders adjusts basic earnings per share for the potentially dilutive impact of redeemable convertible preferred stock warrants, stock options, RSUs, and redeemable convertible preferred stock. As the Company has reported losses for all periods presented, all potentially dilutive securities are anti-dilutive, and accordingly, basic net loss per share equaled diluted net loss per share.
Recently Issued Accounting Pronouncements Not Yet Adopted
In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The amendments improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The new standard will be effective for the Company for the annual periods beginning February 1, 2024, and for interim periods beginning February 1, 2025, with early adoption permitted. Upon adoption, the guidance should be applied retrospectively to all prior periods presented in the financial statements. The Company is currently evaluating the impact of adoption of the standard on disclosures within its consolidated financial statements.
In December 2023, the FASB issued ASU 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures,” which requires disaggregated information about a reporting entity’s effective tax rate reconciliation as well as information on income taxes paid. The guidance is effective for the Company’s fiscal years beginning after February 1, 2025, with early adoption permitted. The Company is currently evaluating the impact of adoption of the standard on its consolidated financial statements.
There have been no other recent accounting pronouncements, changes in accounting pronouncements or recently adopted accounting guidance during the year ended January 31, 2024 that are of significance or potential significance to the Company.
Note 3. Revenue
Deferred Revenue and Remaining Performance Obligations
The Company recognized $227.5 million and $170.1 million of revenues during the years ended January 31, 2024 and 2023, respectively, that were included in the deferred revenue balance at the beginning of the respective period.
Deferred revenue that will be recognized within the next twelve months is recorded as current deferred revenue, and the remaining portion is recorded as noncurrent. As of January 31, 2024, the Company's remaining performance obligations from subscription contracts were $349.0 million, of which the Company expects to recognize approximately 84% as revenues over the next 12 months and the remainder thereafter.
Deferred Contract Acquisition Costs
Deferred contract acquisition costs represent gross deferred contract acquisition costs less accumulated amortization. Sales commissions earned by the Company’s sales force, as well as related payroll taxes, are considered to be incremental and recoverable costs of obtaining a contract with a customer. As a result, these amounts have been capitalized as deferred contract acquisition costs within prepaid and other current assets and other assets on the consolidated balance sheets.
Deferred contract acquisition costs are amortized over a period of benefit ofthree years. The period of benefit was estimated by considering factors such as historical customer attrition rates, the useful life of the Company’s technology, and the impact of competition in the software-as-a-service industry.
The following table summarizes the activity of deferred contract acquisition costs (in thousands):
| Year Ended January 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Beginning balance | $36,583 | $22,771 |
| Capitalization of contract acquisition costs | 24,770 | 28,910 |
| Amortization of deferred contract acquisition costs | (21,972) | (15,098) |
| Ending balance | $39,381 | $36,583 |
| Deferred contract acquisition costs, current | $21,594 | $18,049 |
| Deferred contract acquisition costs, noncurrent | 17,787 | 18,534 |
| Total deferred contract acquisition costs | $39,381 | $36,583 |
Deferred contract acquisition costs, current is presented within prepaid expenses and other current assets in the consolidated balance sheets. Deferred contract acquisition costs, noncurrent is presented within other assets in the consolidated balance sheets.
Note 4. Fair Value Measurements
The following table summarizes, for assets and liabilities measured at fair value, the respective fair value and classification by level of input within the fair value hierarchy (in thousands):
| As of January 31, 2024 | ||||
|---|---|---|---|---|
| Level 1 | Level 2 | Level 3 | Total | |
| Current Assets | ||||
| Cash equivalents | ||||
| Money market funds | $89,561 | $— | $— | $89,561 |
| Commercial paper | — | 4,991 | — | 4,991 |
| Total cash equivalents | $89,561 | $4,991 | $— | $94,552 |
| Marketable securities | ||||
| U.S. treasury bonds | $162,328 | $— | $— | $162,328 |
| Commercial paper | — | 11,670 | — | 11,670 |
| Corporate bonds | — | 72,608 | — | 72,608 |
| Agency bonds | — | 36,195 | — | 36,195 |
| Total marketable securities | $162,328 | $120,473 | $— | $282,801 |
| Total assets | $251,889 | $125,464 | $— | $377,353 |
| As of January 31, 2023 | ||||
|---|---|---|---|---|
| Level 1 | Level 2 | Level 3 | Total | |
| Current Assets | ||||
| Cash equivalents | ||||
| Money market funds | $289,001 | $— | $— | $289,001 |
| Total cash equivalents | $289,001 | $— | $— | $289,001 |
| Marketable securities | ||||
| Corporate bonds | $— | $2,739 | $— | $2,739 |
| Total marketable securities | $— | $2,739 | $— | $2,739 |
| Total assets | $289,001 | $2,739 | $— | $291,740 |
There were no transfers of financial assets or liabilities into or out of Level 3 during the years ended January 31, 2024 and 2023.
The following table summarizes the Company's investments in marketable securities on the consolidated balance sheets (in thousands):
| As of January 31, 2024 | ||||
|---|---|---|---|---|
| AmortizedCost | GrossUnrealizedGains | GrossUnrealizedLosses | EstimatedFair Value | |
| Current Assets | ||||
| U.S. treasury bonds | $162,485 | $85 | $(242) | $162,328 |
| Commercial paper | 11,645 | 25 | — | 11,670 |
| Corporate bonds | 71,930 | 695 | (17) | 72,608 |
| Agency bonds | 36,067 | 128 | — | 36,195 |
| Total marketable securities | $282,127 | $933 | $(259) | $282,801 |
| As of January 31, 2023 | ||||
|---|---|---|---|---|
| AmortizedCost | GrossUnrealizedGains | GrossUnrealizedLosses | EstimatedFair Value | |
| Current Assets | ||||
| Corporate bonds | $2,744 | $— | $(5) | $2,739 |
| Total marketable securities | $2,744 | $— | $(5) | $2,739 |
The following table presents the contractual maturities of the Company’s marketable securities as of January 31, 2024 (in thousands):
| Amortized Cost | Estimated Fair Value | |
|---|---|---|
| Due within one year | $155,743 | $155,813 |
| Due within one to three years | 126,384 | 126,988 |
| Total | $282,127 | $282,801 |
The Company periodically evaluates its investments for expected credit losses. The unrealized losses on the available-for-sale securities were primarily due to unfavorable changes in interest rates subsequent to the initial purchase of these securities. Gross unrealized losses of the Company’s available-for-sale securities that have been in a continuous unrealized loss position for twelve months or longer were immaterial as of January 31, 2024 and January 31, 2023. The Company expects to recover the full carrying value of its available-for-sale securities in an unrealized loss position as it does not intend or anticipate a need to sell these securities prior to recovering the associated unrealized losses. The Company also expects any credit losses would be immaterial based on the high-grade credit rating for each of such available-for-sale securities. As a result, the Company does not consider any portion of the unrealized losses as of January 31, 2024 or January 31, 2023 to represent credit losses.
In April 2020 and November 2022, the Company entered into credit agreements (the “April 2020 Senior Secured Term Loan” and “November 2022 Senior Secured Credit Facility” as defined in Note 7. Debt) with Silicon Valley Bank (“SVB”). The credit facilities are carried at amortized cost, which approximated their fair values as of January 31, 2024 and January 31, 2023. If the credit facilities were measured at fair value in the financial statements, they would be classified as Level 2 in the fair value hierarchy. On March 27, 2023, First Citizens BancShares, Inc. announced that it entered into an agreement to purchase assets and liabilities of SVB, inclusive of the November 2022 Senior Secured Credit Facility.
Note 5. Balance Sheet Components
Property and Equipment, Net
Property and equipment, net, consisted of the following (in thousands):
| As of January 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Leasehold improvements | $100,795 | $98,264 |
| Capitalized internal-use software | 24,061 | 15,005 |
| Furniture and fixtures | 11,732 | 10,325 |
| Desktop and other computer equipment | 2,122 | 1,804 |
| Construction in progress | 326 | 652 |
| Total gross property and equipment | 139,036 | 126,050 |
| Less: Accumulated depreciation and amortization | (42,493) | (31,066) |
| Total property and equipment, net | $96,543 | $94,984 |
Depreciation and amortization expense for the years ended January 31, 2024, 2023, and 2022 was $14.3 million, $12.7 million, and $8.5 million, respectively.
The changes in the carrying value of capitalized internal-use software costs for the periods presented below are as follows (in thousands):
| Amount | |
|---|---|
| Balance as of February 1, 2022 | $2,353 |
| Capitalization of internal-use software costs | 2,756 |
| Amortization of internal-use software costs | (1,074) |
| Balance as of January 31, 2023 | $4,035 |
| Capitalization of internal-use software costs | 9,056 |
| Amortization of internal-use software costs | (2,570) |
| Balance as of January 31, 2024 | $10,521 |
Prepaid Expenses and Other Current Assets
Prepaid expenses and other current assets consisted of the following (in thousands):
| As of January 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Prepaid expenses | $25,029 | $25,134 |
| Deferred contract acquisition costs, current | 21,594 | 18,049 |
| Other current assets | 5,302 | 5,543 |
| Total prepaid expenses and other current assets | $51,925 | $48,726 |
Accrued Expenses and Other Current Liabilities
Accrued expenses and other current liabilities consisted of the following (in thousands):
| As of January 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Accrued payroll liabilities | $19,219 | $22,336 |
| Accrued sales and value-added taxes | 10,770 | 13,347 |
| Accrued taxes for fringe benefits | 9,452 | 8,064 |
| Accrued advertising expenses | 9,276 | 10,565 |
| Accrued consulting expenses | 4,287 | 4,076 |
| Other liabilities | 22,817 | 25,100 |
| Total accrued expenses and other current liabilities | $75,821 | $83,488 |
Note 6. Convertible Notes—Related Party
The Company previously issuedtwo 3.5% unsecured senior mandatory convertible promissory notes in January 2020 (“January 2020 Convertible Note”) and June 2020 (“June 2020 Convertible Note”) (collectively, the “Convertible Notes”) in principal amounts of $300.0 million and $150.0 million, respectively. The Convertible Notes were not transferable except to affiliates, contained no financial or restrictive covenants, and were expressly subordinated in right of payment to any of the Company’s existing or future secured indebtedness.
On July 1, 2021, upon meeting the closing trading price criteria for optional conversion by the Company (based on the Company’s Class A common stock closing trading price during the last 30 trading days of the previous calendar quarter as stated in the original terms of the Convertible Notes), the Company elected to convert both of the Convertible Notes into an aggregate of 17,012,822 shares of the Company’s Class B common stock pursuant to the original terms of the embedded, substantive conversion features in the Convertible Notes. The Company accounted for the conversion by adjusting its additional paid-in capital for the net carrying amount of the Convertible Notes as of July 1, 2021 of $368.5 million (including accrued interest of $20.4 million and the unamortized debt discount of $101.9 million).
Interest expense related to the Convertible Notes recorded prior to the conversion was as follows (in thousands):
| Year Ended January 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Amortization of debt discount | $— | $— | $10,628 |
| Contractual interest expense | — | — | 6,670 |
| Total interest expense | $— | $— | $17,298 |
Note 7. Debt
In April 2020, the Company entered into afive-year $40.0 million term loan agreement with SVB (the “April 2020 Senior Secured Term Loan”) which provided for a senior secured term loan facility, in an aggregate principal amount of up to $40.0 million to be used for the construction of the Company’s corporate headquarters. Interest accrued and was payable monthly based on a floating rate per annum equal to the prime rate (per the Wall Street Journal) plus an applicable margin ranging from 0% to (1.0)% based on the Company’s unrestricted cash balance at the lender. The April 2020 Senior Secured Term Loan was repaid in full and terminated in November 2022.
In November 2022, the Company entered into an agreement for afour-year credit facility (as amended on April 13, 2023, the “November 2022 Senior Secured Credit Facility”) with SVB, which refinanced the April 2020 Senior Secured Term Loan. The November 2022 Senior Secured Credit Facility provides for senior secured credit facilities in the aggregate principal amount of $150.0 million, including a senior secured term loan facility in an aggregate principal amount of $50.0 million and a revolving loan facility in an aggregate principal amount of up to $100.0 million, including a $30.0 million letter of credit sub-facility, maturing on November 7, 2026. On March 27, 2023, First Citizens BancShares, Inc. announced that it entered into an agreement to purchase assets and liabilities of SVB, inclusive of the November 2022 Senior Secured Credit Facility.
Borrowings under the November 2022 Senior Secured Credit Facility may be designated as ABR Loans or SOFR Loans, subject to certain terms and conditions under the agreement. ABR Loans accrue interest at a rate per annum equal to the ABR plus an applicable margin of 1.25%. Term SOFR Loans accrue interest at a rate per annum equal to the applicable adjusted term SOFR rate, which is equal to the applicable term SOFR rate plus a term SOFR adjustment of 10 basis points, provided such adjusted term SOFR rate shall not be less than zero, plus an applicable margin of 2.25%. Interest accrues and is payable on a monthly basis.
The November 2022 Senior Secured Credit Facility contains customary conditions to borrowing, events of default, and covenants, including covenants that restrict the Company’s ability to incur indebtedness, make or hold investments, execute certain change of control transactions, business combinations or other fundamental changes to the business, dispose of assets, make certain types of restricted payments or enter into certain related party transactions, subject to customary exceptions. In addition, the November 2022 Senior Secured Credit Facility contains financial covenants, including a consolidated adjusted quick ratio of 1.25 to 1.00, as well as a minimum cash adjusted EBITDA, each tested on a quarterly basis.
Pursuant to the terms of the November 2022 Senior Secured Credit Facility, the Company may issue letters of credit which may reduce the total amount available for borrowing under the revolving credit facility. Additionally, the Company is required to pay an annual commitment fee that accrues at a rate of 0.15% per annum on the unused portion of the borrowing commitments under the revolving credit facility. The Company had an aggregate of $21.4 million of letters of credit outstanding under the revolving credit facility as of January 31, 2024, and the Company’s total available borrowing capacity under the revolving credit facility was $78.6 million as of January 31, 2024.
As of January 31, 2024, $50.0 million was drawn and $46.9 million was outstanding under the November 2022 Senior Secured Credit Facility. As of January 31, 2024, the Company was in compliance with all financial covenants.
In conjunction with the close of the November 2022 Senior Secured Credit Facility, the Company paid upfront issuance fees of $0.4 million. The upfront fees are amortized over the remaining term of the agreement. Upfront issuance fees allocated to the revolving credit facility of $0.2 million are presented in the Company’s consolidated balance sheet within other assets.
The net carrying amounts of the November 2022 Senior Secured Credit Facility were as follows (in thousands):
| As of January 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Principal | $46,875 | $50,000 |
| Accrued interest | 297 | 218 |
| Unamortized loan issuance costs | (132) | (179) |
| Net carrying amount | $47,040 | $50,039 |
| Credit facilities, current | $3,422 | $3,343 |
|---|---|---|
| Credit facilities, noncurrent | $43,618 | $46,696 |
The net carrying amount of the current portion of the term loan is presented within accrued expenses and other current liabilities in the consolidated balance sheets.
The expected future principal payments for all borrowings as of January 31, 2024 is as follows (in thousands):
| Fiscal year ending January 31, | Contractual Maturity |
|---|---|
| 2025 | $3,125 |
| 2026 | 5,000 |
| 2027 | 38,750 |
| Total principal payments | $46,875 |
Note 8. Commitments and Contingencies
Standby Letters of Credit
As of January 31, 2024 and 2023, the Company had several letters of credit outstanding related to its operating leases totaling $21.4 million and $23.6 million, respectively. The letters of credit expire at various dates between 2025 and 2034.
Purchase Commitments
In January 2021, the Company entered into a 60-month contract with Amazon Web Services for hosting-related services. Pursuant to the terms of the contract, the Company is required to spend a minimum of $103.5 million over the term of the agreement. The commitment may be offset by up to $7.3 million in additional credits subject to the Company meeting certain conditions of the agreement, which have been earned as of January 31, 2024. As of January 31, 2024 the Company had purchase commitments remaining of $46.5 million for hosting-related services and $12.2 million with various parties primarily for software-based services which are not reflected on the Company’s consolidated balance sheet.
Indemnification Agreements
The Company has entered into indemnification agreements with its directors and officers that may require the Company to indemnify its directors and officers against any liabilities that may arise by reason of their status or service as directors or officers, other than liabilities arising from willful misconduct of the individual.
Additionally, in the ordinary course of business, the Company enters into agreements of varying scope and terms pursuant to which it agrees to indemnify customers, vendors, lessors, business partners, and other parties with respect to certain matters, including, but not limited to, losses arising out of the breach of such agreements, services to be provided by the Company, or from intellectual property infringement claims made by third parties. For the years ended January 31, 2024 and 2023, no demands have been made upon the Company to provide indemnification under such agreements, and there are no claims that the Company is aware of that could have a material adverse effect on its financial position, results of operations, or cash flows.
Contingencies
From time to time in the normal course of business, the Company may be subject to various claims and other legal matters arising in the ordinary course of business. As of January 31, 2024 and 2023, the Company believes that none of its current legal proceedings would have a material adverse effect on its financial position, results of operations, or cash flows.
Note 9. Leases
The Company leases real estate facilities under non-cancelable operating leases with various expiration dates through fiscal 2034. The Company has no lease agreements that are classified as finance leases.
The components of lease costs, lease term, and discount rate for operating leases are as follows:
| Year Ended January 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Operating lease costs (in thousands) | $40,897 | $36,542 | $36,494 |
| Short-term lease costs (in thousands) | 3,488 | 2,946 | 3,240 |
| Variable lease costs (in thousands) | 2,663 | 2,269 | 1,452 |
| Total lease costs | $47,048 | $41,757 | $41,186 |
| Weighted-average remaining lease term (in years) | 8.8 | 10.2 | 11.4 |
| Weighted-average discount rate | 9.5% | 9.6% | 9.5% |
Supplemental cash flow information related to operating leases are as follows (in thousands):
| Year Ended January 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Cash paid for amounts included in the measurement of operating lease liabilities | $41,389 | $34,816 | $12,021 |
| Right-of-use assets obtained in exchange for new operating lease liabilities | $29,887 | $17,809 | $7,997 |
| Right-of-use reductions related to operating lease impairments | $4,900 | $— | $— |
Future minimum lease payments (net of tenant improvement receivables) under non-cancelable operating leases with initial lease terms in excess of one year included in the Company’s lease liabilities as of January 31, 2024, are as follows (in thousands):
| Fiscal year ending January 31, | Operating Lease Payments |
|---|---|
| 2025 | $40,608 |
| 2026 | 38,859 |
| 2027 | 39,074 |
| 2028 | 39,180 |
| 2029 and thereafter | 197,049 |
| Total undiscounted operating lease payments | 354,770 |
| Less: imputed interest | (120,507) |
| Total operating lease liabilities | $234,263 |
During the year ended January 31, 2024, the Company executed a sublease for a portion of its corporate office space in San Francisco, California. The Company evaluated the associated asset group for impairment, which included the ROU assets and underlying property and equipment for the lease. The Company compared the expected future undiscounted cash flows to the carrying value and determined the respective asset group was not recoverable. The Company calculated the fair value based on the present value of the estimated cash flows from the sublease for the remaining lease term and compared the estimated fair value to its carrying value, which resulted in a $5.0 million consolidated impairment charge. The fair value of the operating lease ROU assets and associated property and equipment was estimated as of the sublease execution date using level 3 inputs based on an income approach by converting future sublease cash inflows and outflows to a single present value. Estimated cash flows were discounted at a rate commensurate with the inherent risks associated with the asset group to arrive at an estimate of fair value. The impairment charge was included in general and administrative expenses in the consolidated statements of operations.
The sublease commenced during the year ended January 31, 2024 and has a lease term offive years. The Company has classified the sublease as an operating lease. Sublease income was $0.8 million for the year ended January 31, 2024. There wasno sublease income for the year ended January 31, 2023 and January 31, 2022. The Company recognizes sublease income as a reduction of lease expense in the Company’s consolidated statements of operations.
Operating lease amounts in the table above do not include sublease income payments of $8.7 million. As of January 31, 2024, the future total minimum sublease payments to be received were as follows (in thousands):
| Fiscal year ending January 31, | Sublease Payments to be Received |
|---|---|
| 2025 | $1,556 |
| 2026 | 1,919 |
| 2027 | 1,976 |
| 2028 | 2,036 |
| 2029 and thereafter | 1,208 |
| Total sublease income | $8,695 |
Note 10. Net Loss per Share
The Company computes net loss per share using the two-class method required for multiple classes of common stock and participating securities. The rights, including the liquidation and dividend rights, of the Class A common stock and Class B common stock are substantially identical, other than voting rights. Accordingly, the Class A common stock and Class B common stock share equally in the Company’s net income and losses.
The following table presents the calculation of basic and diluted net loss per share (in thousands, except per share data):
| Year Ended January 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Numerator: | |||
| Net loss | $(257,030) | $(407,768) | $(288,342) |
| Denominator: | |||
| Weighted-average shares used in calculating net loss per share, basic and diluted | 220,406 | 200,034 | 176,401 |
| Net loss per share, basic and diluted | $(1.17) | $(2.04) | $(1.63) |
The potential shares of common stock that were excluded from the computation of diluted net loss per share for the period presented because including them would have been anti-dilutive are as follows (in thousands):
| Year Ended January 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Stock options | 9,788 | 11,941 | 14,383 |
| Restricted stock units | 17,190 | 14,591 | 8,812 |
| Early exercised stock options | — | 28 | 205 |
| Shares issuable pursuant to the 2020 Employee Stock Purchase Plan | 485 | 528 | 249 |
| Total | 27,463 | 27,088 | 23,649 |
As noted in Note 6. Convertible Notes—Related Party, the Convertible Notes were converted into 17,012,822 shares of the Company’s Class B common stock in July 2021. The shares underlying the Convertible Notes were previously excluded from diluted EPS because the effect would have been anti-dilutive.
Note 11. Stockholders’ Equity (Deficit)
Common Stock
There aretwo classes of common stock that total 1,500,000,000 authorized shares:1,000,000,000 authorized shares of Class A common stock and 500,000,000 authorized shares of Class B common stock. The rights of the holders of Class A common stock and Class B common stock are identical, except with respect to voting and conversion. Each share of Class A common stock is entitled toone vote per share. Each share of Class B common stock is entitled to 10 votes per share and is convertible intoone share of Class A common stock. Prior to the Direct Listing, which was completed on September 30, 2020, all 73,577,455 outstanding shares of redeemable convertible preferred stock were converted into an equivalent number of shares of Class B common stock. There are 139,238,565 shares of Class A common stock and 85,489,359 shares of Class B common stock issued and outstanding as of January 31, 2024. There were 128,803,395 shares of Class A common stock and 85,489,359 shares of class B common stock issued and outstanding as of January 31, 2023.
All changes in the number of shares of common stock outstanding for the years ended January 31, 2024 and 2023, were related to changes in Class A common stock.
Private Placement—Related Party
In September 2022, the Company issued and sold 19,273,127 shares of its Class A common stock to the Company’s CEO in a private placement transaction at a purchase price of $18.16 per share, based on the closing trading price of the Company’s Class A common stock on September 2, 2022, for aggregate gross proceeds of approximately $350 million. The Company incurred issuance costs related to the private placement of $2.7 million. The Company recorded the proceeds (net of issuance costs) of $347.3 million as additional paid-in capital within the consolidated statements of stockholders’ equity (deficit) for the year ended January 31, 2023.
Stock Plans
The Company has a 2009 Stock Plan (the “2009 Plan”), a 2012 Amended and Restated Stock Plan (the “2012 Plan”), and a 2020 Equity Incentive Plan (the “2020 Plan”). Each plan was initially established to grant equity awards to employees and consultants of the Company to assist in attracting, retaining, and motivating employees and consultants and to provide incentives to promote the success of the Company’s business. The number of shares reserved for issuance under the 2020 Plan increased by 9,414,923 shares of Class A common stock on February 1, 2022, by 10,714,637 shares of Class A common stock on February 1, 2023, and by 11,236,396 shares of Class A common stock on February 1, 2024 pursuant to the evergreen provisions of the 2020 Plan.
There areno outstanding awards under the 2009 Plan, and new issuances under the 2012 Plan terminated upon completion of the Direct Listing. Awards outstanding under the 2012 Plan continue to be outstanding and are governed by the provisions of the 2012 Plan. The 2020 Plan provides for the grant of incentive stock options (“ISOs”), within the meaning of Section 422 of the Code, nonstatutory stock options (“NSOs”), stock appreciation rights, restricted stock awards (“RSUs”), performance-based stock awards, and other forms of equity compensation.
ISOs may be granted only to Company employees (including officers and directors who are also employees). NSOs may be granted to Company employees and consultants. Options under the 2020 Plan may be granted for periods of up to 10 years. The exercise price of ISOs and NSOs shall not be less than 100% of the estimated fair value of the shares on the date of grant as determined by the Company’s board of directors (the “Board of Directors”). Options granted generally vest over four years and vest at a rate of 25% upon the first anniversary of the vesting commencement date and 1/48 per month thereafter.
The Company has outstanding RSU awards issued pursuant to the 2012 Plan and 2020 Plan. RSUs granted generally vest on a predefined rate over a period offour years contingent upon continuous service.
Shares of common stock purchased under the 2012 Plan are subject to certain restrictions and repurchase rights.
Stock Options
Option activity under the Company’s combined stock plans is set forth below (in thousands, except years and per share data):
| Number ofShares · Weighted-AverageExercisePrice · Weighted-AverageRemainingContractual Term(in years) · AggregateIntrinsic Value | ||||||
|---|---|---|---|---|---|---|
| Balances as of January 31, 2023 | 11,941 | $2.96 | 5.1 | $149,738 | ||
| Options granted | — | — | ||||
| Options exercised | (2,101) | 2.31 | ||||
| Options forfeited | (52) | 5.51 | ||||
| Balances as of January 31, 2024 | 9,788 | 3.09 | 4.2 | $140,292 | ||
| Vested and exercisable at January 31, 2024 | 9,568 | 3.10 | 4.2 | $137,045 | ||
| Vested and expected to vest at January 31, 2024 | 9,788 | 3.09 | 4.2 | $140,292 | ||
The weighted-average grant-date fair value of options granted and the total intrinsic value of options exercised during the periods presented were as follows:
| Year Ended January 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Weighted-average grant-date fair value per share | $— | $— | $— |
| Aggregate intrinsic value of options exercised (in thousands) | $38,757 | $52,687 | $404,964 |
Early Exercise of Employee Options
The 2009 Plan and 2012 Plan allow for the early exercise of stock options. The consideration received for an early exercise of an option is considered to be a deposit of the exercise price, and the related dollar amount is recorded as a liability and reflected in accrued expenses and other current liabilities and other liabilities in the consolidated balance sheets. This liability is reclassified to additional paid-in capital as the awards vest. If a stock option is early exercised, the unvested shares may be repurchased by the Company in case of employment termination at the price paid by the purchaser for such shares. No shares were subject to repurchase as of January 31, 2024 and a total of 27,864 shares were subject to repurchase as of January 31, 2023.
Restricted Stock Units
The Company’s RSU activity is set forth below (in thousands, except per share data):
| Number ofShares · Weighted-AverageGrant Date Fair Value · AggregateIntrinsic Value | ||||
|---|---|---|---|---|
| Unvested RSUs at January 31, 2023 | 14,591 | $27.75 | $226,145 | |
| RSUs granted | 13,344 | 20.01 | ||
| RSUs vested | (7,404) | 25.63 | ||
| RSUs forfeited | (3,341) | 25.75 | ||
| Unvested RSUs at January 31, 2024 | 17,190 | 23.04 | $299,450 | |
| RSUs vested, not yet released at January 31, 2024 | 806 | 32.82 | ||
Stock-Based Compensation Expense
Stock-based compensation for stock-based awards to employees and non-employees in the Company’s consolidated statements of operations for the periods below were as follows (in thousands):
| Year Ended January 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Cost of revenues | $1,549 | $1,658 | $806 |
| Research and development | 112,619 | 100,083 | 57,480 |
| Sales and marketing | 59,217 | 58,504 | 29,631 |
| General and administrative | 29,033 | 28,717 | 16,644 |
| Total stock-based compensation expense | $202,418 | $188,962 | $104,561 |
The stock-based compensation expense related to options granted to non-employees for the years ended January 31, 2024, 2023, and 2022 was not material.
Total unrecognized compensation costs related to unvested awards not yet recognized under all equity compensation plans was as follows:
| As of January 31, 2024 | ||
|---|---|---|
| Unrecognized Expense (in thousands) | Weighted-Average Expected Recognition Period (in years) | |
| Stock options | $285 | 3.7 |
| RSUs | 358,188 | 2.9 |
| Total unrecognized stock-based compensation expense | $358,473 | 2.9 |
| As of January 31, 2023 | ||
|---|---|---|
| Unrecognized Expense (in thousands) | Weighted-Average Expected Recognition Period (in years) | |
| Stock options | $3,230 | 1.6 |
| RSUs | 369,302 | 2.9 |
| Total unrecognized stock-based compensation expense | $372,532 | 2.9 |
2020 Employee Stock Purchase Plan
In September 2020, the Board of Directors adopted and approved the 2020 Employee Stock Purchase Plan which became effective on the effective date of the Company's registration statement on Form S-1 filed with the SEC in connection with the Direct Listing. The ESPP initially reserved and authorized the issuance of up to a total of 2,000,000 shares of Class A common stock to participating employees. The number of shares reserved under the ESPP was automatically increased on February 1, 2021 to 3,614,801 shares of Class A common stock, to 5,497,785 on February 1, 2022, to 7,640,712 on February 1, 2023, and to 9,887,991 on February 1, 2024 pursuant to the evergreen provisions of the ESPP.
Subject to any limitations contained therein, the ESPP allows eligible participants to contribute, through payroll deductions, up to 15% of their eligible compensation to purchase shares of the Company’s Class A common stock at a purchase price equal to 85% of the fair market value of the Class A common stock on either the first day of the offering period or the purchase date, whichever fair market value is lower. The ESPP generally provides for consecutive 24-month offering periods, each consisting offour separate consecutive purchase periods of approximatelysix months in length. The ESPP also includes atwo year look back in purchase price, including a reset feature. The reset feature is triggered if the price on the date of purchase is less than the price on the first day of the offering period.
During the years ended January 31, 2024, 2023, and 2022 the Company recog nized $11.4 million, $12.8 million, and $8.0 million respectively, of stock-based compensation expense related to the ESPP. The Company withheld $7.2 million and $6.9 million as of January 31, 2024 and 2023, respectively, in contributions from employees. As of January 31, 2024, total unrecognized compensation cost related to the ESPP was $10.4 million, which will be amortized over a weighted average vesting term of 1.1 years.
The following assumptions were used to calculate the fair value of shares to be granted under the ESPP during the period:
| Year Ended January 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Risk-free interest rate | 4.1% - 5.5% | 0.9%-4.0% | 0.1%-0.2% |
| Expected term | 0.5 - 2.0 years | 0.5 - 2.0 years | 0.5 - 2.0 years |
| Dividend yield | —% | 0% | 0% |
| Expected volatility | 39.3% - 60.3% | 46.2% - 64.1% | 36.8% - 53.8% |
Note 12. Employee Benefit Plans
In January 2011, the Company adopted a defined contribution retirement savings plan under Section 401(k) of the Internal Revenue Code. This plan covers all employees within the United States who meet minimum age and service requirements and allows participants to defer a portion of their annual compensation on a pre-tax basis. The Company’s contributions to the plan may be made at the discretion of the Board of Directors. There have beenno contributions to the plan by the Company since the inception of the plan as of January 31, 2024. Additionally, the Company engages in required pension plans of respective countries in which operations exist.
Note 13. Interest Income and Other Income (Expense), Net
Interest income and other income (expense), net consist of the following (in thousands):
| Year Ended January 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Interest income | $21,128 | $7,910 | $506 |
| Unrealized gains (losses) on foreign currency transactions | (164) | 801 | (953) |
| Other non-operating expense | (340) | (1,778) | (1,089) |
| Total interest income and other income (expense), net | $20,624 | $6,933 | $(1,536) |
Other non-operating expense consists primarily of realized foreign currency gains and losses on transactions in the periods presented.
Note 14. Income Taxes
The components of the provision for income taxes were as follows (in thousands):
| Year Ended January 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Current: | |||
| United States | $— | $— | $— |
| State | 318 | 45 | — |
| Foreign | 3,239 | 4,009 | 3,031 |
| Total current | $3,557 | $4,054 | $3,031 |
| Deferred: | |||
| United States | $— | $— | $— |
| State | — | — | — |
| Foreign | 148 | 821 | 206 |
| Total deferred | 148 | 821 | 206 |
| Total provision for income taxes | $3,705 | $4,875 | $3,237 |
The components of income (loss) before income taxes were as follows (in thousands):
| Year Ended January 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| United States | $(262,894) | $(413,505) | $(292,759) |
| Foreign | 9,569 | 10,612 | 7,654 |
| Total | $(253,325) | $(402,893) | $(285,105) |
The reconciliation between the statutory federal income tax and the Company’s effective tax rates as a percentage of loss before income taxes were as follows:
| Year Ended January 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Federal tax rate | 21.0% | 21.0% | 21.0% |
| Stock-based compensation expense | (3.6) | (2.4) | 25.0 |
| Change in valuation allowance | (21.4) | (23.1) | (52.8) |
| Transaction costs | — | (0.1) | — |
| Research and development credits | 3.5 | 4.9 | 7.7 |
| Convertible debt interest | — | — | (1.3) |
| Other | (1.0) | (1.5) | (0.8) |
| Effective income tax rate | (1.5)% | (1.2)% | (1.2)% |
The major components of deferred tax assets (liabilities) were as follows (in thousands):
| As of January 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Deferred tax assets: | ||
| Net operating loss carryforwards | $285,152 | $282,705 |
| Research and development tax credits | 96,548 | 87,059 |
| Stock-based compensation | 14,552 | 14,731 |
| Reserves and accrued expenses | 7,860 | 6,714 |
| Operating lease liabilities | 56,532 | 52,922 |
| R&D expense capitalization under Sec. 174 | 125,080 | 76,765 |
| Total deferred tax assets | 585,724 | 520,896 |
| Valuation allowance | (532,423) | (470,548) |
| Total deferred tax assets, net of valuation allowance | 53,301 | 50,348 |
| Deferred tax liabilities: | ||
| Right of use asset | (43,320) | (41,434) |
| Deferred commissions | (8,588) | (8,020) |
| Depreciation and amortization | (2,704) | (2,123) |
| Total deferred tax liabilities | (54,612) | (51,577) |
| Net deferred tax liabilities | $(1,311) | $(1,229) |
The valuation allowance increased by $61.9 million, $113.6 million, and $174.4 million during the years ended January 31, 2024, 2023, and 2022, respectively. The increase in the valuation allowance during the years ended January 31, 2024 and 2023 were primarily driven by research and development expense capitalization under Sec. 174, loss carryforwards, and tax credits generated in the United States. The increase in the valuation allowance during the year ended January 31, 2022 was primarily driven by losses and tax credits generated in the United States. As of January 31, 2024, 2023, and 2022, the Company believes it is not more likely than not that the deferred tax assets will be fully realizable and continues to maintain a full valuation allowance against its net deferred tax assets.
As of January 31, 2024, the Company had federal and state net operating loss carryforwards of $1,167.3 million and $665.2 million, respectively. The federal and state net operating losses, if not used, will begin to expire in 2029. Federal net operating losses generated after January 31, 2018 will carry forward indefinitely.
As of January 31, 2024, the Company has federal and California research and development tax credit carryforwards of $85.0 million and $54.8 million, respectively, to offset future taxable income. The federal research and development tax credits, if not used, will begin to expire in 2030, while the state tax credit carryforwards may be carried forward indefinitely.
The Tax Reform Act of 1986 limits the use of net operating loss and tax credit carryforwards in certain situations where changes occur in the stock ownership of a company. Under Section 382 of the Internal Revenue Code of 1986, as amended, the Company’s ability to utilize net operating loss carryforwards or other tax attributes in any taxable year may be limited if the Company has experienced an “ownership change.” Generally, a Section 382 “ownership change” occurs if one or more stockholders or groups of stockholders who owns at least 5% of a corporation’s stock increases its ownership by more than 50 percentage points over its lowest ownership percentage within a specified testing period. Similar rules may apply under state tax laws. The Company has completed a Section 382 study of transactions in its stock through January 31, 2020. The study concluded that the Company has experienced ownership changes since inception and that its utilization of net operating loss carryforwards will be subject to annual limitations. However, it is not expected that the annual limitations will result in the expiration of tax attribute carryforwards prior to utilization.
Under the Tax Cuts and Jobs Act of 2017, research and development costs are no longer fully deductible and are required to be capitalized and amortized for U.S. tax purposes effective January 1, 2022. This tax law change did not result in any U.S. federal tax liability due to the use of existing U.S. federal net operating loss carryforwards. It did result in incremental state tax liability and expense due to limitations on the use of existing state net operating loss carryforwards.
Foreign withholding taxes have not been provided for the cumulative undistributed earnings of the Company’s foreign subsidiaries as of January 31, 2024 due to the Company’s intention to permanently reinvest such earnings.
No liability related to uncertain tax positions is recorded in the financial statements due to the fact the liabilities have been netted against deferred attribute carryovers.
A reconciliation of the beginning and ending amounts of gross unrecognized tax benefits was as follows (in thousands):
| As of January 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Balance at the beginning of the year | $31,738 | $19,826 |
| Increases - current period tax positions | 5,444 | 7,666 |
| Increases - prior period tax positions | — | 4,246 |
| Decreases - prior period tax positions | (2,222) | — |
| Balance at the end of the year | $34,960 | $31,738 |
The Company hadno accrued interest and penalties related to unrecognized tax benefits as of January 31, 2024 or January 31, 2023. As of January 31, 2024, there are no unrecognized tax benefits that, if recognized, would affect the Company’s effective tax rate. The Company does not expect that its uncertain tax positions will materially change in the next 12 months.
The Company files federal and state tax returns in the United States and in various foreign jurisdictions. The Company’s tax years since inception are open to examination by federal and state taxing authorities, and the tax years 2018 and forward remain open in various foreign jurisdictions.
Note 15. Geographic Information
The following tables set forth revenues and long-lived assets, including operating lease ROU assets, by geographic area for the periods presented below (in thousands):
| Year Ended January 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| United States | $398,034 | $330,238 | $219,305 |
| International | 254,470 | 216,974 | 159,132 |
| Total revenues | $652,504 | $547,212 | $378,437 |
Revenues by geography are based on the shipping address of the customer.
Long-Lived Assets
| As of January 31, | ||
|---|---|---|
| 2024 | 2023 | |
| United States | $271,844 | $265,582 |
| International | 6,430 | 5,591 |
| Total long-lived assets | $278,274 | $271,173 |
Note 16. Related Party Transactions
In January and June 2020, the Company issued Convertible Notes to a trust affiliated with the Company’s CEO. The Company elected to convert these Convertible Notes on July 1, 2021. See Note 6. Convertible Notes—Related Party for further details.
During the fiscal year ended January 31, 2020, the Company began leasing certain office facilities from a company affiliated with Board members of the Company. Rent payments made under these leases totaled $1.6 million and $2.0 million for the years ended January 31, 2024 and 2023, respectively. The Company has entered into various agreements with the same company and has recognized revenue of $0.9 million and $0.7 million for the years ended January 31, 2024 and 2023, respectively. There wasno customer receivable amount as of January 31, 2024 and a customer receivable amount of $1.7 million as of January 31, 2023.
The Company has entered into an advertising agreement with a company affiliated with a Board member of the Company. Payments under this agreement totaled $1.1 million and $1.8 million for the years ended January 31, 2024 and 2023, respectively.
The Company has entered into an advertising agreement with a company affiliated with a Board member of the Company. Payments under this agreement totaled $2.0 million and $3.2 million for the years ended January 31, 2024 and 2023, respectively.
In September 2022, the Company issued and sold 19,273,127 shares of its Class A common stock to the Company’s CEO in a private placement transaction at a purchase price of $18.16 per share, based on the closing trading price of the Company’s Class A common stock on September 2, 2022, for aggregate gross proceeds of approximately $350 million. See Note 11. Stockholders’ Equity (Deficit) for further details.
Note 17. Restructuring
On November 15, 2022, the Company authorized a plan to reduce its global headcount by approximately 9%. This plan was adopted as part of a restructuring intended to improve operational efficiencies and operating costs and better align the Company’s workforce with current business needs, top strategic priorities, and key growth opportunities.
Non-recurring charges in connection with the headcount reductions include notice period and severance payments, employee benefits, and related facilitation costs as well as non-cash expenditures related to the accelerated vesting of share-based awards, which resulted in $9.3 million of restructuring costs for the year ended January 31, 2023. The headcount reductions, including cash payments, were substantially completed by the end of fiscal 2023.
The consolidated balance sheet as of January 31, 2023 includes $0.9 million of restructuring costs classified in current liabilities.
The restructuring costs are recognized in the consolidated statement of operations for the year ended January 31, 2023 as follows:
| Severance and Related Charges | Stock-Based Compensation Expense (Benefit) | Total | |
|---|---|---|---|
| Cost of revenues | $512 | $38 | $550 |
| Research and development | 33 | 2 | 35 |
| Sales and marketing | 5,921 | 661 | 6,582 |
| General and administrative | 1,914 | 179 | 2,093 |
| Total | $8,380 | $880 | $9,260 |
The following table summarizes the Company’s restructuring liabilities (in thousands):
| Restructuring Liability | |
|---|---|
| Beginning balance as of February 1, 2023 | $873 |
| Charges (benefit) | (147) |
| Payments | (707) |
| Foreign currency translation adjustment | (19) |
| Ending balance as of January 31, 2024 | $— |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.